Presentation Summary : The Role of SGLT-2 Inhibitors in the Management of Patients with Type 2 Diabetes Lawrence Blonde, MD Director, Ochsner Diabetes Clinical Research Unit,
Source : http://www.nysafp.org/images/uploads/misc/1326909268_SGLT-2%20powerpoint%20AFP.ppt
Presentation Summary : Role of the Kidney in T2DM - WorldWIDE Diabetes
Source : http://www.worldwidediabetes.org/wp-content/downloads/role-of-the-kidney.ppt
Presentation Summary : Rationale for SGLT2 Inhibitors. The SGLT2 is a glucose transporter responsible for 90% of glucose reabsorption. Selective SGLT2 inhibitors could reduce blood glucose ...
Source : http://www.inosteo.org/UserFiles/File/PowerPoint/2012%20IOA%20Annual%20Convention/Saturday/Advances%20in%20Type%202%20Diabetes.Novel%20Agents%20that%20Target%20the%20Kidney.Freeman.pptx
Presentation Summary : Several selective SGLT2 inhibitors (SGLT2i) are currently under development2,3. SGLT2 inhibition results in increased urinary glucose excretion (UGE) ...
Source : http://www.go-acop.org/sites/default/files/webform/posters/Nucci-SGLT2i-Poster-ACoP-2011.ppt
Presentation Summary : Sodium-Glucose-Cotransporter-2 (SGLT2) Inhibitors: The Latest Class of Oral Agents. Canagliflozin and Dapagliflozin are the first FAD approved SGLT-2 In.
Source : http://adc2014.com/presentations/Osama-Hamdy/001.pptx
Presentation Summary : Glycemic Management in Type 2 Diabetes Antihyperglycemic Therapy * Noninsulin ... Bydureon Liraglutide Victoza SGLT2 inhibitors Increase urinary excretion of ...
Source : http://outpatient.aace.com/sites/all/files/T2DM_S5_Treatment_041813.ppt
Presentation Summary : Author: ETreventi Created Date: 08/07/2014 12:33:17 Title: The Kidney and Glucose Homeostasis: Why Target SGLT2 in Diabetes Treatment? Last modified by
Source : http://img.medscape.com/images/829/831/829831_slides.pptx
Presentation Summary : Sodium-glucose co-transporter 2 (SGLT2) inhibitors and their place in therapy . Katee Lira, PharmD. PGY2 Ambulatory Care Pharmacy Resident. St. Vincent Joshua Max ...
Source : http://www.indianapharmacists.org/Files/2014%20ACON%20Clinicl%20Pearls/Clinical%20Pearls%20LIRA.pptx
Presentation Summary : ... compound should become active in early 2015 and we will be receiving milestone payments during the development of our SGLT2 Inhibitor.
Source : http://www.sironabiochem.com/wp-content/uploads/2014/02/SBM-Introduction-01292014.pptx
Presentation Summary : Model-Based Meta-Analysis of HbA1c, Weight, and FPG in Type 2 Diabetes: Focus on SGLT2 inhibitors William S. Denney and Gianluca Nucci Pfizer Global R&D, Groton/New ...
Source : http://www.go-acop.org/sites/default/files/webform/posters/Denney-SGLT-2%20Poster-ACoP%202011.ppt
Presentation Summary : Hyperglycemia in Type 2 Diabetes Sodium Glucose Cotransporters Location of Sodium Glucose Cotransporters in the Kidney SGLT2 Inhibitors Rationale for SGLT2 ...
Source : http://img.medscape.com/images/32761/779655_slides.ppt
Presentation Summary : Specific SGLT2 inhibitors are being developed as a novel means of controlling hyperglycaemia in T2DM. Contribution of Tissues to Fasting Plasma Glucose. Liver. 80%.
Source : http://familydoctornm.org/presentations/57-presentations/20140802-1030-2.pptx
Presentation Summary : ... In the Kidneys The kidneys reabsorb glucose in the proximal tubule, mostly through sodium-glucose-cotransporter 2 (SGLT2) In diabetes, ...
Source : http://www.segageriatrics.com/wp/wp-content/uploads/2012/11/rahimi-discussion1.ppt
Presentation Summary : Sodium-glucose-cotransporter-2 (SGLT2) inhibitors. ... Management of type 2 diabetes: new and future developments in treatment. The Lancet, Vol 378. July 9 2011, 182-195.
Source : http://www.segageriatrics.com/wp/wp-content/uploads/2011/09/New-DMII-Treatments.pptx
Presentation Summary : Objectives. Pharmacists will be able to: Describe SGLT2 inhibitors. Compare available SGLT-2 inhibitors. Identifyideal candidates for SGLT2 inhibitors
Source : http://www.drsamrotation.com/uploads/1/9/8/6/19863509/jardiance_presesentation_rahul.pptx
Presentation Summary : SGLT2 inhibitor. Increase urinary excretion of glucose. Canagliflozin. Invokana. ... Diabetes Care. 2012;35:1364-1379. Garber AJ, et al. Endocr Pract. 2013;19:327-336.
Source : http://outpatient.aace.com/sites/all/files/T2DM-S5-Treatment-051713.pptx
Presentation Summary : Review the role of the kidney in the maintenance of normal glucose homeostasis. 6. Discuss the role of the SGLT2 inhibitors in the treatment of Type 2 DM. 7. Define ...
Source : http://www.sanap.org/Diabetes_flyer_2014_registration_form.ppt
Presentation Summary : DISCLOSURES. Served as a consultant to Sanofi-Aventis. PI on 2 clinical Trials (DPP4 – Takeda, SGLT2 – BI) Acknowledge Dr. David Lieb and The National Diabetes ...
Source : http://www.acponline.org/about_acp/chapters/va/13mtg/aloi_advancementdiabetes.pptx
Presentation Summary : Once daily SGLT2 inhibitor indicated as add-on therapy. Additional HgbA1c reduction -0.32% vs. -0.14% SU add-on.
Source : http://www.correctionalhealthconference.com/sites/correctionalhealthconference.com/files/Drug%20Utilization%20and%20the%20Pharmaceutical%20Pipeline_Erik%20Hamel.pptx
Presentation Summary : Figure 1 Schematic representation of the distribution of sodium–glucose cotransporters along an unrolled nephron Ferrannini, E. & Solini, A. (2012) SGLT2 inhibition ...
Source : http://www.nature.com/nrendo/journal/v8/n8/slides/nrendo.2011.243-pf1.ppt
Presentation Summary : SGLT2 is located in the S1 segment of the proximal tubule and facilitates reabsorption of 90% of the glucose it ... Diabetes Obes Metab.January.2012/p1/lines A6-A8; ...
Source : http://www.ruraldoctors.ie/wp-content/uploads/2014/03/Dr.MC-Durkan-Whats-New-Diabetes.pptx